Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Overview of B Team, Implementation Barriers, and Grow Strategies


 

Overview of B Team, Implementation Barriers, and Grow Strategies

 
This Opioid Training Initiative course was developed to prepare healthcare professionals who work with patients with opioid use disorder (OUD).   Through this course, Dr. Mason and Dr. Janzen describe the development and basic components of a buprenorphine program in an acute care hospital setting while also describing the effectiveness of interprofessional collaborations for patient care.  Further, they describe evidence-based best practices in treatment of OUD during acute hospitalization.  
 
This program includes a second video with interviews of B-Team members at Ascension Hospital in Austin, Texas.  The Team describes the interprofessional support and nature of the team with additional information on how the Team was able to form.  This video does not carry continuing education credits, but is included as supplemental information.
 
The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.

Faculty

Kristen Janzen, PharmD, BCPS
Clinical Assistant Professor of Pharmacy Practice
The University of Texas at Austin College of Pharmacy

Kristin Janzen is a Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy. After graduating from UT College of Pharmacy, she completed a combined PGY1 & 2 Pharmacotherapy residency at Butler University and Indiana University Health in Indianapolis, IN, where she stayed on faculty for a year prior to returning home to UT Austin. She currently practices at Dell Seton Medical Center at the University of Texas in Internal Medicine, where she precepts APPE students and residents on academic internal medicine rotations. She has been recognized for both didactic and experiential teaching and was awarded the College of Pharmacy Educator of the Year, the Austin-Temple-Waco Region Preceptor of the Year, and Wm. Arlyn Koesel Preceptor of the Year Awards. Her research and teaching interests focus on core medicine disease states, such as pulmonology, cardiology, diabetes, and interprofessional education.
 

DISCLOSURE: Dr Janzen has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

 

Kirsten Mason, PharmD, BCPS
Regional Clinical Pharmacy Manager
Ascension Texas

Dr. Kirsten Mason is a graduate of the University of Tennessee Health Science Center College of Pharmacy. She completed her PGY1 Pharmacy Residency at Memphis Veterans Affairs Medical Center and her PGY2 Internal Medicine Residency at University Medical Center Brackenridge in Austin, TX. Immediately after residency training, Dr. Mason accepted a clinical pharmacy specialist position in cardiology at Northwestern Memorial Hospital in Chicago. In 2016, she had an opportunity to relocate back to Austin and she joined Dell Seton Medical Center at University of Texas as an Internal Medicine Clinical Pharmacy Specialist. In this role, she assisted in the development of an inpatient opioid use disorder treatment service. In November of 2018, Dr. Mason transitioned roles within Ascension Texas to a Regional Clinical Pharmacy Manager with an emphasis on project management and pain management. She also serves as a preceptor for University of Texas College of Pharmacy and Texas A&M College of Pharmacy. Dr. Mason continues to advocate for treatment of opioid use disorder across the continuum of care and educate healthcare providers about medications for opioid use disorder. More recently, Dr. Mason is serving as Interim Director of Pharmacy at Ascension Seton Northwest.
 

DISCLOSURE: DISCLOSURE: Dr. Mason has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose:

Consultant: Macromoltek Grant Consultant Review of Conflicts Policy:

The UT Austin College of Pharmacy has a very strict policy to ensure against commercial conflicts of interest in CE programming. For this conference, the planning committee picks two committee members who have appropriate backgrounds to review content, and report any potential conflict of interest to the CPE Director. If conflict issues are discovered, they are addressed with speakers to make appropriate changes. Evaluations are collected from all participants with specific questions around the listed conflicts of commercial interest.


Learning Objectives

  • Describe the development and basic components of a buprenorphine program in an acute care hospital setting
  • Discuss the effectiveness of interprofessional collaborations for patient care
  • Describe evidence-based best practices in treatment of OUD during acute hospitalization
 

Continuing Education Information

ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete online evaluation.  Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.

Note: This program may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances, as outlined by (TSBP rule 295.8(d)(1)(C)) and (TMB criteria).

The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™  .    


This activity provides up to 1.00 of nursing continuing education through the University of Texas at Austin School of Nursing. University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.


The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work provides continuing education in accordance with the criteria and standards of the Texas Board of Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists and Licensed Psychologist under Texas Administrative Code, Title 22, Part 34. § 781.509. Complaints about this program may be made to TSBSWE, 333 Guadalupe St., Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205 • bhec.texas.gov/texas-state-board-of-social-worker-examiners/


This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians
  • Physicians
  • Psychiatrists
  • Physician Assistant
  • Social Workers
  • Advance Practice Nurses (CME)
  • Nurse Practitoners (CME)

 

 

 

Overview of B Team, Implementation Barriers, and Grow Strategies

 
Kristin Janzen, PharmD, BCPS
Clinical Assistant Professor, Pharmacy Practice The University of Texas at Austin College of Pharmacy
Internal Medicine Clinical Specialist, Dell Seton Medical Center
 
Kirsten Mason, PharmD, BCPS
Regional Clinical Pharmacy Manager
Ascension Texas

 

This module may be counted as one hour of CE related to Prescribing and Monitoring Controlled Substances, as outlined by TSBP rule 295.8(d)(1)(C)
 
 

LEARNING OBJECTIVES

  • Describe evidence-based best practices in treatment of OUD during acute hospitalization
  • Describe the development and basic components of a buprenorphine program in an acute care hospital setting
  • Discuss the effectiveness of interprofessional collaborations for patient care
 
This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.

Activity Number

0067-0000-21-109-L01-P/T

Release Date: Jun 18, 2021
Credit Expiration Date: Jun 18, 2023

CE Hours

1.00